2-27137288-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000335524.7(PRR30):c.1042G>A(p.Asp348Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000564 in 1,614,200 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000335524.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PRR30 | NM_178553.4 | c.1042G>A | p.Asp348Asn | missense_variant | 3/3 | ENST00000335524.7 | NP_848648.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PRR30 | ENST00000335524.7 | c.1042G>A | p.Asp348Asn | missense_variant | 3/3 | 1 | NM_178553.4 | ENSP00000335017 | P1 | |
PRR30 | ENST00000432962.2 | c.548G>A | p.Arg183Gln | missense_variant | 4/4 | 3 | ENSP00000393468 |
Frequencies
GnomAD3 genomes AF: 0.000145 AC: 22AN: 152196Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000915 AC: 23AN: 251414Hom.: 0 AF XY: 0.0000515 AC XY: 7AN XY: 135900
GnomAD4 exome AF: 0.0000472 AC: 69AN: 1461886Hom.: 0 Cov.: 33 AF XY: 0.0000358 AC XY: 26AN XY: 727244
GnomAD4 genome AF: 0.000144 AC: 22AN: 152314Hom.: 0 Cov.: 32 AF XY: 0.000175 AC XY: 13AN XY: 74478
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 14, 2021 | The c.1042G>A (p.D348N) alteration is located in exon 3 (coding exon 1) of the PRR30 gene. This alteration results from a G to A substitution at nucleotide position 1042, causing the aspartic acid (D) at amino acid position 348 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at